Comprehensive Obesity Registry - A First for Bariatric Research.

RemedyMD's Solution Addresses Institute of Medicine's Top 100 Priorities and Shifts Focus towards Research Based on More Comprehensive Scientific Evidence

SALT LAKE CITY -- RemedyMD (www.RemedyMD.com), the leading provider of disease registry software, today announced the first nationwide comprehensive obesity registry for bariatrics. The new registry was developed to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

Details about the registry:

http://www.remedymd.com/cer100/comp_obesity.html

Aligned with the Institute of Medicine's Top 100 Priorities for Comparative Effectiveness Research (CER), RemedyMD's comprehensive obesity registry for bariatrics compares the effectiveness of many treatment strategies including:

various bariatric surgery procedure, behavioral interventions, and pharmacologic treatment on the resolution of obesity-related outcomes such as:

* Diabetes

* Hypertension

* Musculoskeletal disorders

The registry provides detailed data collected from over 100 practices that can be used in addressing many pressing questions such as: what is the effect of each type of bariatric surgery on a patient's Hga1c levels, levels of insulin required, and weight reduction over a 3-year period. The registry includes all of the applications, data infrastructure, and tools that clinicians and researchers need to gather, synthesize and analyze both phenotypic and genotypic data simultaneously.

"Our experience has shown when you view and report across all data types at the same time, you discover patterns and associations that are indistinguishable using traditional methodologies," said Gary D. Kennedy, Founder and CEO of RemedyMD.

RemedyMD's new obesity registry includes a comprehensive set of electronic data collection (EDC) forms that are specific to bariatric research, ad hoc reporting capability, and pattern recognition tools that assist users in identifying the most effective treatment options.

In support of this initiative RemedyMD is seeking additional partners who have existing data that addresses the specific needs of bariatric researchers. All institutions involved in comparative effectiveness research that are planning on submitting grant proposals for AHRQ funding are invited to visit: http://www.remedymd.com/cer100/comp_obesity.html.

RemedyMD Resources:

Resource Kit for Comparative Effectiveness Research: www.remedymd.com/cer_kit.html

Ways to leverage Comprehensive Obesity Registry for Bariatrics: www.remedymd.com/cer100/comp_obesity.html

Comparative Effectiveness Research: www.remedymd.com/cer_home.html

Disease Registry Software: www.remedymd.com/registries_home.html

Institute of Medicine's Top 100 Priorities for CER: www.remedymd.com/cer_kit.html

About RemedyMD

RemedyMD[R] is the leading provider of specialized software applications, tools, and data necessary for comparative effectiveness research with more than 100 pre-built clinical, disease, and patient registry software applications. RemedyMD solutions are personalized to the institution, the clinical specialty, and to the individual provider's preferences enabling researchers to identify new patterns, facilitate new discoveries, and improve medical outcomes. For more information, visit www.RemedyMD.com.